Maria Bennett

Maria is founder and president of SPR Therapeutics Inc. Previously, she served as vice president of clinical affairs at NDI Medical LLC, where she played a vital role in the development of a neurostimulation system addressing urinary incontinence. The company was acquired by Medtronic in 2008 for $42 million. Prior to NDI, she was a clinical project manager at Boston Scientific, leading a team that conducted a clinical trial demonstrating safety and efficacy of an innovative angioplasty balloon, and achieving a 510(k) clearance.